Therapeutic Asset Ratings
5,108 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rituximab
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P3
BB
(66)
Rituximab
Leukemia
University of Chicago
P3
BB
(66)
Rituximab
Primary Mediastinal Large B-Cell Lymphoma
City of Hope Medical Center
P3
BB
(66)
Rituximab
Richter Transformation
SWOG Cancer Research Network
P3
BB
(66)
Rivoceranib
Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(66)
Rmc-6236
Pancreatic Ductal Adenocarcinoma
Tango Therapeutics, Inc.
P3
BB
(66)
Rocbrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P3
BB
(66)
Rocbrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P3
BB
(66)
Romidepsin
T-Cell Non-Hodgkin Lymphoma
Sichuan University
P3
BB
(66)
Rph-075
Cutaneous Melanoma
R-Pharm
P3
BB
(66)
Rucaparib
Peritoneum Cancer
pharmaand GmbH
P3
BB
(66)
Saruparib
Metastatic Prostate Carcinoma
AstraZeneca
P3
BB
(66)
sb27
Non-Small Cell Lung Carcinoma
Samsung Bioepis Co., Ltd.
P3
BB
(66)
Semaglutide
Alzheimer Disease
The Methodist Hospital Research Institute
P3
BB
(66)
Semaglutide
Type 1 Diabetes Mellitus
Nordsjaellands Hospital
P3
BB
(66)
Serine D-Form
Schizophrenia
University of Minnesota
P3
BB
(66)
Serplulimab
Malignant Pancreatic Neoplasm
Zhejiang Cancer Hospital
P3
BB
(66)
Sipuleucel-T
Castration-Resistant Prostate Carcinoma
City of Hope Medical Center
P3
BB
(66)
Sipuleucel-T
Prostate Cancer
City of Hope Medical Center
P3
BB
(66)
Sirolimus
Myeloproliferative Neoplasm
Masonic Cancer Center, University of Minnesota
P3
BB
(66)
Sirolimus
Graft Versus Host Disease
Zachariah Michael DeFilipp
P3
BB
(66)
Sirolimus
Non-Hodgkin Lymphoma
Umoja Biopharma
P3
BB
(66)
Sitagliptin
Cardiovascular Disorder
Brigham and Women's Hospital
P3
BB
(66)
Sonlicromanol
Maternally-Inherited Diabetes And Deafness
Khondrion BV
P3
BB
(66)
Sorafenib
Cutaneous Melanoma
National Cancer Institute (NCI)
P3
BB
(66)
Showing 1326 to 1350 of 5,108 assets
Previous
Page 54 of 205
Next